Avantis Total Equity Markets ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.18
資產淨值: 54.34
成立日期: 30/01/2026
 
分析
市值分佈:
59.79%
大市值
1.30%
中市值
0.46%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 13/06/2026 05:49) 總持有投資項目: 1296  
0%
 
100%
     10大 (22.05%)
代號 名稱 佔比% 持有日期
NTLAIntellia Therapeutics0.0000330/04/2026
PRVAPrivia Health Group0.0000330/04/2026
SCHLScholastic Corp0.0000330/04/2026
CLARClarus Corp0.0000230/04/2026
CLBCore Laboratories0.0000230/04/2026
CTKBCytek Biosciences0.0000230/04/2026
CUECue Biopharma Inc.0.0000230/04/2026
DLHCDLH Holdings Corp0.0000230/04/2026
ENOVEnovis Corp0.0000230/04/2026
HAFCHanmi Financial Corp0.0000230/04/2026
INSPInspire Medical Systems0.0000230/04/2026
JBIOJade Biosciences Inc0.0000230/04/2026
KROSKeros Therapeutics0.0000230/04/2026
LBRDALiberty Broadband Corp0.0000230/04/2026
MGPIMGP Ingredients0.0000230/04/2026
NPKNational Presto Industries0.0000230/04/2026
RAREUltragenyx Pharmaceutical0.0000230/04/2026
SCSCScanSource0.0000230/04/2026
SDGRSchrodinger0.0000230/04/2026
SIRISiriusXM Holdings Inc0.0000230/04/2026
  1    2    3    4    5    6    7    8    9    10    11    12    13    14    15    16    17    18    19    20    21    22    23    24    25    26    27    28    29    30    31    32    33    34    35    36    37    38    39    40    41    42    43    44    45    46    47    48    49    50    51    52    53    54    55    56    57    58    59    60    61    62    63   64    65  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.